MedTrace Logo

Fever Tracking Study

NCT05475067 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61

Last updated 2022-07-26

No results posted yet for this study

Summary

The aim of this study is to investigate the feasibility of continuous fever tracking of participants having fever symptoms in a home setting, using a core body temperature (CBT) sensor. CBT as measured by the wearable sensors will be coampared with CBT as measured by ingestible electronc pills (reference).

A secondary research question is, if the CBT behavior of the the participants in a home setting can be compared to previously described CBT profiles in the literature, and if special patterns can be identified.

Conditions

  • Core Body Temperature in Healthy Subjects
  • Immune Response to mRNA COVID-19 Vaccination

Sponsors & Collaborators

  • greenTEG AG

    collaborator INDUSTRY

  • University Hospital, Basel, Switzerland

    lead OTHER

Principal Investigators

  • Jens Eckstein, Prof. Dr. · University Hospital, Basel, Switzerland

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-10-07
Primary Completion
2022-03-03
Completion
2022-03-05

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05475067 on ClinicalTrials.gov